Fig. 7

Receiver operating characteristic curves predicting sustained virological and serological response after 48-week Peg-IFN-α treatment. (A-B) Receiver operating characteristic curves for LY6E at baseline, weeks 12, 24 as they predict sustained virological and serological response. (C-D) Receiver operating characteristic curves for TRIM6 at baseline weeks 12, 24 as they predict sustained virological and serological response. The Youden index was used to maximize the potential effectiveness of the biomarkers. AUC: area under the curve